Cardura
$ 40,00 – $ 313,00Price range: $ 40,00 through $ 313,00
Cartidin
$ 65,00 – $ 278,00Price range: $ 65,00 through $ 278,00
Careprost
$ 42,00 – $ 367,00Price range: $ 42,00 through $ 367,00
Careprost is a highly effective ophthalmic solution containing Bimatoprost, designed to manage intraocular pressure in patients with open-angle glaucoma or ocular hypertension. By increasing the natural outflow of fluid from the eye, this medication helps maintain a healthy ocular environment and protects long-term vision. Beyond its primary medical use, Careprost is widely recognized for its ability to treat hypotrichosis, a condition characterized by inadequate or sparse eyelashes. Regular application promotes the growth of longer, thicker, and darker lashes, significantly enhancing their natural appearance over time. This versatile formula provides a reliable solution for those seeking both ocular health support and aesthetic eyelash improvement.
Active substance: Bimatoprost
SKU:
Careprost
Categories: Eye Care, Woman's Health
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Careprost belongs to a group of medicines known as synthetic prostaglandin analogs, containing the active ingredient bimatoprost at a 0.03% concentration. In the United States, bimatoprost ophthalmic preparations are regulated as prescription-only (Rx) medications that require evaluation by a licensed healthcare provider. This therapeutic agent is primarily evaluated for ocular conditions, including elevated intraocular pressure, as well as structural growth deficiencies of the eyelashes.
When evaluating therapeutic options, healthcare providers weigh the demonstrated clinical efficacy of prostaglandin analogs against potential side effects like iris pigmentation changes. On one hand, bimatoprost exhibits potent activity in increasing fluid outflow from the eye and promoting hair follicle growth phases; on the other hand, careful adherence to administration guidelines is necessary to prevent adverse cutaneous and ocular reactions.
| Property | Details |
|---|---|
| Active Ingredient (INN) | Bimatoprost (0.03%) |
| Therapeutic Class | Prostaglandin Analog |
| Dosage Form | Ophthalmic Solution |
| Route of Administration | Topical Ophthalmic / Cutaneous Application to Eyelid Margin |
| Prescription Status | Prescription Only (Rx) |
| Primary Purpose | Lowering intraocular pressure; treating eyelash hypotrichosis |
Clinical Profile and Application
Main Uses and Mechanism of Action
Main Uses
Careprost is formulated with bimatoprost 0.03%, an active compound authorized for specific ophthalmic and dermatological applications under professional supervision. Primarily, bimatoprost ophthalmic solution is indicated to reduce elevated intraocular pressure in adult patients diagnosed with open-angle glaucoma or ocular hypertension. By effectively managing intraocular pressure, the medication helps mitigate the risk of progressive optic nerve damage and subsequent visual field loss. In addition to intraocular pressure management, bimatoprost 0.03% is prescribed for the treatment of hypotrichosis of the eyelashes, a condition characterized by inadequate or insufficient eyelash growth. When applied along the upper eyelid margin, it enhances eyelash length, thickness, and darkness. Any use outside of FDA-approved label indications is considered off-label and must be individually assessed by a qualified medical professional.
How the Drug Works
The underlying mechanism of action of bimatoprost involves mimicking naturally occurring prostamides, which are structural lipid compounds involved in ocular fluid dynamics and cellular regulation. Within the eye, bimatoprost lowers intraocular pressure by increasing the outflow of aqueous humor through both the trabecular meshwork and the uveoscleral pathways. This dual-action fluid drainage prevents pressure accumulation within the anterior chamber. When applied topically to the base of the eyelashes, bimatoprost acts directly on hair follicles during the anagen phase of the hair growth cycle. It works by expanding the proportion of hair follicles in the growth phase and prolonging the duration of this period, ultimately resulting in enhanced length and density of the lashes.
How It’s Absorbed and Eliminated
Following topical administration to the ocular surface or upper eyelid margin, bimatoprost exhibits minimal systemic absorption. Pharmacokinetic evaluations show that systemic exposure remains extremely low, with peak plasma concentrations occurring within 10 minutes post-instillation. The systemic elimination half-life of bimatoprost is estimated at approximately 45 minutes, with approximately 88% of the drug bound to human plasma proteins. Bimatoprost undergoes oxidation, N-deethylation, and glucuronidation within the body, yielding structural metabolites that are excreted via renal (up to 67%) and biliary (up to 25%) pathways. Because therapeutic action occurs locally at the ocular tissue or hair follicle, systemic accumulation is minimal under recommended dosage regimens.
Dosing Schedule and Administration Guidelines
Dosing Schedule
Administration of Careprost depends on the targeted indication and must follow exact prescriber directives. For managing intraocular pressure, the typical recommendation is instillation of one drop into the affected eye(s) once daily in the evening. Higher frequency of application does not increase efficacy and may paradoxically reduce the intraocular pressure-lowering effect. For eyelash hypotrichosis, one drop is applied to a sterile single-use applicator and evenly distributed along the skin of the upper eyelid margin at the base of the eyelashes once daily at night. Contact lenses must be removed prior to application and may be reinserted 15 minutes following instillation. Care must be taken to avoid contacting the lower eyelid or spreading the solution to unintended skin areas.
If You Skip a Dose
If a scheduled application of Careprost is missed, patients should skip the missed application and resume treatment at the next scheduled evening dose. Doubling the dose or applying extra drops to compensate for a missed application is not recommended. Excessive application can increase the risk of localized adverse effects, such as ocular hyperpigmentation or irritation, without providing additional therapeutic benefit.
Compatibility with Other Medicines
While systemic drug interactions are rare due to low systemic absorption, localized drug interactions within the ocular environment can occur. Concurrent use of bimatoprost with other prostaglandin analogs (such as latanoprost or travoprost) should be monitored closely, as simultaneous administration can paradoxically increase intraocular pressure or diminish the pressure-lowering efficacy of both agents. If using multiple topical ophthalmic medications, each product should be administered at least 5 minutes apart to prevent wash-out of active compounds. Patients taking systemic antihypertensive medications should inform their prescriber, as cumulative effects on vascular resistance are theoretically possible, though clinically uncommon.
Safety Guidelines and Considerations
Adverse Reactions and Important Precautions
Adverse Reactions
Clinical evaluations demonstrate that bimatoprost 0.03% is generally tolerated, though specific localized adverse reactions are well-documented. The most frequently reported ocular side effect is conjunctival hyperemia (eye redness), occurring in approximately 15% to 45% of patients. Other common reactions include ocular pruritus (itching), skin hyperpigmentation around the eyelid, growth of unwanted hair near the application site, and mild dry eye symptoms. Notably, bimatoprost may cause increased brown pigmentation of the iris, which is typically permanent and may not be noticed until several months or years after starting treatment. Periorbital tissue changes, including deepening of the eyelid sulcus, have also been reported with prolonged use.
Important Precautions
Careprost should be used with caution in individuals with active intraocular inflammation, such as uveitis or iritis, as the medication may exacerbate inflammatory responses. Patients with macular edema or aphakic patients should also undergo risk assessment before initiation. In terms of special populations, safety and effectiveness in pediatric patients under 16 years of age have not been established. For pregnant or nursing women, bimatoprost should be used only if the potential benefit justifies the potential risk to the fetus or infant, as controlled data in human pregnancy are limited. Patients undergoing ocular surgery or experiencing intercurrent ocular conditions should seek immediate medical re-evaluation regarding continued use.
Signs of Improvement
When used for intraocular pressure reduction, the therapeutic effect of bimatoprost typically begins within 4 hours of administration, reaching peak effect at approximately 8 to 12 hours. Patients will not visually notice pressure changes; routine tonometry by an eye care professional is required to confirm effectiveness. When prescribed for eyelash hypotrichosis, subtle visual improvements in eyelash length are generally observed after 4 to 8 weeks of continuous nightly application, with full results usually apparent at 12 to 16 weeks. Discontinuation of treatment typically results in a gradual return to baseline eyelash appearance over several weeks to months.
Storage and Frequently Asked Questions
Storage and Expiration
Careprost ophthalmic solution should be stored at controlled room temperature between 36°F and 77°F (2°C to 25°C), away from direct sunlight, excess heat, and moisture. The container must be kept tightly closed when not in use. Patients should avoid touching the dropper tip or applicator to any surface, including the eye or fingers, to prevent microbial contamination. Any remaining solution should be discarded according to the expiration date printed on the packaging, or within the timeframe recommended by a pharmacist after opening.
Common Questions
What happens if the solution gets into my eye during eyelash application?
Careprost is an ophthalmic solution formulated for ocular safety. If a small amount accidentally enters the eye during application to the upper eyelid margin, it is generally harmless and does not need to be flushed out, provided the eye was properly evaluated by a prescriber for bimatoprost tolerance.
Will changes in my eye color go away if I stop using Careprost?
While skin hyperpigmentation along the eyelid often reverses after stopping treatment, changes in iris pigmentation (increased brown color) are typically permanent. Patients should discuss potential cosmetic changes with their eye care specialist prior to starting therapy.
Can I wear contact lenses while using this medication?
Yes, but soft contact lenses must be removed prior to applying Careprost, as the formulation contains benzalkonium chloride, a preservative that can be absorbed by soft lenses. Lenses may be reinserted 15 minutes after application.
How long does it take for eyelashes to return to normal after stopping?
If treatment is discontinued, eyelash growth gradually declines over several weeks to months, eventually returning to the appearance present prior to initiating treatment.
Can Careprost be applied to the lower eyelashes?
No, Careprost should only be applied to the skin at the base of the upper eyelashes. Application to the lower eyelid increases the risk of excessive hair growth in unintended surrounding skin areas and local hyperpigmentation.
In accordance with federal regulations, this material is educational. Only a licensed prescriber can determine whether a medication is appropriate for your individual condition.
Additional information
| Dosage |
0.3mg |
|---|---|
| Package |
1 bottles ,2 bottles ,3 bottles ,4 bottles ,5 bottles ,6 bottles ,7 bottles ,8 bottles ,9 bottles ,10 bottles |
| Ενεργός Ουσία |
Related products
Alesse
$ 65,00 – $ 208,00Price range: $ 65,00 through $ 208,00
Active substance: ethinyloestradiol, Levonorgestrel
More Details
This product has multiple variants. The options may be chosen on the product page
Alkeran
$ 112,00 – $ 513,00Price range: $ 112,00 through $ 513,00
Active substance: Melphalan
More Details
This product has multiple variants. The options may be chosen on the product page
Bimat
$ 60,00 – $ 330,00Price range: $ 60,00 through $ 330,00
Active substance: Bimatoprost
More Details
This product has multiple variants. The options may be chosen on the product page
Conjubrook
$ 215,00 – $ 705,00Price range: $ 215,00 through $ 705,00
Active substance: Conjugated Estrogens
More Details
This product has multiple variants. The options may be chosen on the product page
Etodolac
$ 46,00 – $ 390,00Price range: $ 46,00 through $ 390,00
Active substance: Etodolac
More Details
This product has multiple variants. The options may be chosen on the product page
Female Cialis
$ 20,00 – $ 340,00Price range: $ 20,00 through $ 340,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Femalegra
$ 50,00 – $ 305,00Price range: $ 50,00 through $ 305,00
Active substance: Sildenafil
More Details
This product has multiple variants. The options may be chosen on the product page
Ferrous
$ 60,00 – $ 487,00Price range: $ 60,00 through $ 487,00
Active substance: Ferrous sulfate
More Details
This product has multiple variants. The options may be chosen on the product page
